CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Panbela Therapeutics Inc   (PBLA)
Other Ticker:  
 

Panbela Therapeutics Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Panbela Therapeutics Inc in the first quarter 2023?
Due to the lack of equity, it was not possible to calculate Panbela Therapeutics Inc 's return on equity (ROE) in its first quarter 2023

What is ROE?



Return On Equity (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Equity Change -61.48 % - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -36 -35 -34 -31 -12
Return On Equity (TTM) - - -3672.25 % -495.52 % -127.71 %
PBLA's Total Ranking # # # # #
Equity (TTM) in Millions 3 -8 -8 -5 7
Seq. Equity Change - - - - -35.56 %
Seq. Net Income Change - - - - -

Back to PBLA Management Effectiveness >> PBLA's 5 Years Annual ROE >> Compare PBLA ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 


PBLA Annual Return On Equity (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Equity in Millions -8 10 8 1 0
Y / Y Equity Change - 20.88 % 509.96 % 416.79 % -
Net Income in Millions -35 -10 -5 -6 -6
Y / Y Net Income Change - - - - -
Return On Equity - -99.25 % -56.44 % -447.65 % -2203.36 %

Back to PBLA Management Effectiveness >> PBLA's 5 Years Annual ROE >> Compare PBLA ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
PBLA's' Return on Equity at Yahoo Finance
PBLA's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Roe for PBLA's Competitors
Return On Equity for Panbela Therapeutics Inc 's Suppliers
Roe for PBLA's Customers




Companies with similar Return On Equity at Mar 31 2023, within Healthcare Sector ROE
Catalyst Biosciences Inc   526.04 %
Theravance Biopharma inc   371.53 %
Biovie Inc   345.80 %
Omeros Corporation  303.40 %
Glucotrack Inc   272.80 %
Amgen Inc   209.99 %
Acelrx Pharmaceuticals Inc  178.53 %

Date modified: 2023-05-05T20:49:15+00:00



Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071